Results 51 to 60 of about 191 (111)

Molecular mechanisms and multi-target therapeutic strategies of diabetic nephropathy: from pathogenesis to precision interventions. [PDF]

Front Pharmacol
Gong J, Fang X, Yao X, Xue F, Qi G, Chen B, Sun H.   +6 more
europepmc   +1 more source

Advances in the treatment of diabetic peripheral neuropathy by modulating gut microbiota with traditional Chinese medicine. [PDF]

World J Diabetes
Li YY, Guan RQ, Hong ZB, Wang YL, Pan LM.   +4 more
europepmc   +1 more source

Therapeutic potential of <i>Abelmoschus manihot</i>: mechanisms of action and clinical use in traditional Chinese medicine formulas. [PDF]

Front Pharmacol
Xue C, Ge H, Liu Y, Zhao Y, Huang W, Lu Z, Ye Q, Chen X, Cao Z.   +8 more
europepmc   +1 more source

The same heterozygous Col4A4 mutation triggered different renal pathological changes in Chinese family members. [PDF]

Front Genet, 2023
Zhu F, Li Y, Wang Y, Yao Y, Zeng R.
europepmc   +1 more source

A review of advances in the treatment of diabetic nephropathy by modulating intestinal flora with natural products of traditional Chinese medicine. [PDF]

Front Pharmacol
Wang T, Chen M, Xu J, Qiao Y, Huang X, Yan X, Zhang F.   +6 more
europepmc   +1 more source

Metabolomic Analysis of Stephania tetrandra-Astragalus membranaceus Herbal Pair-Improving Nephrotic Syndrome Identifies Activation of IL-13/STAT6 Signaling Pathway. [PDF]

Pharmaceuticals (Basel), 2023
Xu B, Yao M, Liu Z, Zhang S, Wang B, Han Y, Gao J, Wu D, Wang X.   +8 more
europepmc   +1 more source

Single-nucleus transcriptomics identifies SPON1 as a candidate mediator of the anti-fibrotic effect of <i>Abelmoschus manihot</i> (L.) in diabetic kidney disease. [PDF]

Am J Transl Res
Zhu C, Zhu Z, Wang R, Xiao Y, Wang Q, Wang X, Yin J, Wei L.   +7 more
europepmc   +1 more source

Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine. [PDF]

Front Endocrinol (Lausanne)
Sheng L, Cao Z, Wang L, Xu Y, Gui D.
europepmc   +1 more source

The Therapeutic Strategies for Uremic Toxins Control in Chronic Kidney Disease. [PDF]

Toxins (Basel), 2021
Lu PH, Yu MC, Wei MJ, Kuo KL.
europepmc   +1 more source

Meta analysis of efficacy and safety of Huangkui capsule combined with ARB drugs in the treatment of primary glomerular diseases

Linchuang shenzangbing zazhi, 2022
Wu Wen, Tu Wei-ping
openaire   +1 more source